跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Exelon Patch 5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Exelon Patch 5
Approved
STANDARD
Exelon Patch 5
LTS Lohmann Therapie-Systeme AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c235a9853e87960b
Company
LTS Lohmann Therapie-Systeme AG
Type
Standard
Approval Details
Approval Id
c235a9853e87960b
Drug Approval Philippines Name
Exelon Patch 5
Product Name
Exelon Patch 5
Registration Number
DRP-7420
Brand Name
Exelon Patch 5
Generic Name
Rivastigmine
Dosage Form
Transdermal Patch
Dosage Strength
4.6mg/24 hours
Manufacturer
LTS Lohmann Therapie-Systeme AG
Importer
Novartis Healthcare Philippines, Inc.
Distributor
Novartis Healthcare Philippines, Inc.
Company Detail Path
/organization/lts-lohmann-therapie-systeme-ag
Issuance Date
02 November 2023
Expiry Date
07 October 2028
Pharmacologic Category
Anti-dementia
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c235a9853e87960b
Type
Standard
Back to Philippines FDA Approvals